Illumina Operating Cash Flow decreased by 10.0% to $289.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.4%, from $240.00M to $289.00M. Over 2 years (FY 2023 to FY 2025), Operating Cash Flow shows an upward trend with a 50.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $253.00M | $282.00M | $172.00M | $125.00M | $147.00M | $10.00M | $105.00M | $139.00M | $224.00M | $77.00M | $80.00M | $316.00M | $364.00M | $240.00M | $234.00M | $284.00M | $321.00M | $289.00M |
| QoQ Change | — | +11.5% | -39.0% | -27.3% | +17.6% | -93.2% | +950.0% | +32.4% | +61.2% | -65.6% | +3.9% | +295.0% | +15.2% | -34.1% | -2.5% | +21.4% | +13.0% | -10.0% |
| YoY Change | — | — | — | -50.6% | -47.9% | -94.2% | -16.0% | — | +52.4% | +670.0% | -23.8% | +127.3% | +62.5% | +211.7% | +192.5% | -10.1% | -11.8% | +20.4% |